Tilray Stock Forecast, Price & News

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 9 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Tilray stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TLRY, but not buy additional shares or sell existing shares.
View analyst ratings for Tilray or view top-rated stocks.

Wall Street analysts have given Tilray a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Tilray wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Tilray saw a decline in short interest during the month of May. As of May 28th, there was short interest totaling 29,970,000 shares, a decline of 13.9% from the May 13th total of 34,810,000 shares. Based on an average daily trading volume, of 25,660,000 shares, the short-interest ratio is presently 1.2 days. Approximately 7.1% of the company's shares are short sold.
View Tilray's Short Interest.

Tilray is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Tilray.

Tilray Inc (NASDAQ:TLRY) issued its quarterly earnings results on Monday, May, 10th. The company reported ($0.19) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.10) by $0.09. The company earned $48.02 million during the quarter, compared to analysts' expectations of $61.86 million. Tilray had a negative trailing twelve-month return on equity of 136.31% and a negative net margin of 336.84%.
View Tilray's earnings history.

Tilray's stock was trading at $7.09 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, TLRY shares have increased by 145.0% and is now trading at $17.37.
View which stocks have been most impacted by COVID-19.

14 Wall Street analysts have issued 12-month price targets for Tilray's stock. Their forecasts range from $4.75 to $32.00. On average, they anticipate Tilray's stock price to reach $20.28 in the next year. This suggests a possible upside of 16.7% from the stock's current price.
View analysts' price targets for Tilray or view top-rated stocks among Wall Street analysts.

32 employees have rated Tilray CEO Brendan Kennedy on Glassdoor.com. Brendan Kennedy has an approval rating of 51% among Tilray's employees. This puts Brendan Kennedy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Tilray include (ALIOF) (ALIOF), Canopy Growth (CGC), Charlie's (CHUC), STADA Arzneimittel Aktiengesellschaft (STDAF), Cronos Group (CRON), USANA Health Sciences (USNA), Aurora Cannabis (ACB), True Drinks (TRUU), Sundial Growers (SNDL), HEXO (HEXO), ChromaDex (CDXC), Canopy Rivers (RIV), MediWound (MDWD), Natural Alternatives International (NAII) and Mannatech (MTEX).
View all of TLRY's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Square (SQ).

(TLRY) raised $135 million in an initial public offering on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company served as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Tilray's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Mirae Asset Global Investments Co. Ltd. (1.39%), Graham Capital Management L.P. (0.52%), TIG Advisors LLC (0.28%), Swiss National Bank (0.17%), Princeton Global Asset Management LLC (0.17%) and Freestone Capital Holdings LLC (0.12%). Company insiders that own Tilray stock include Brendan Kennedy, Carl A Merton, Christine StClare, Maryscott Greenwood and Michael Auerbach.
View institutional ownership trends for Tilray.

TLRY stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., JPMorgan Chase & Co., Cubist Systematic Strategies LLC, Bridges Investment Management Inc., Sigma Planning Corp, HBK Sorce Advisory LLC, Aua Capital Management LLC, and GSA Capital Partners LLP. Company insiders that have sold Tilray company stock in the last year include Brendan Kennedy, Carl A Merton, Christine StClare, Maryscott Greenwood, and Michael Auerbach.
View insider buying and selling activity for Tilray or view top insider-selling stocks.

TLRY stock was purchased by a variety of institutional investors in the last quarter, including Graham Capital Management L.P., TIG Advisors LLC, Mirae Asset Global Investments Co. Ltd., Capital Fund Management S.A., Swiss National Bank, Axiom Investment Management LLC, Axiom Investment Management LLC, and Princeton Global Asset Management LLC.
View insider buying and selling activity for Tilray or or view top insider-buying stocks.

Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TLRY stock can currently be purchased for approximately $17.37.

Tilray has a market capitalization of $7.77 billion and generates $210.48 million in revenue each year. The company earns $-271,070,000.00 in net income (profit) each year or ($0.83) on an earnings per share basis.

Tilray employs 1,030 workers across the globe.

The official website for Tilray is www.tilray.com.

Tilray is headquartered at 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2.

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The company can be reached via phone at 206-432-9325.